Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of HS-10382 in Patients With Chronic Myeloid Leukemia. — Stella

Home/CML, Chronic Phase/A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.

View on ClinicalTrials.gov

Recruiting

Back to CML, Chronic Phase trials

A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei

Key details

Phase

Early testing

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Enrollment target

~108 participants

Started

April 2022

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 74 Years

Last updated January 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.